NO137754C - Analogifremgangsmaate for fremstilling av terapeutisk aktive steroidforbindelser - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive steroidforbindelserInfo
- Publication number
- NO137754C NO137754C NO2406/72A NO240672A NO137754C NO 137754 C NO137754 C NO 137754C NO 2406/72 A NO2406/72 A NO 2406/72A NO 240672 A NO240672 A NO 240672A NO 137754 C NO137754 C NO 137754C
- Authority
- NO
- Norway
- Prior art keywords
- therapeutically active
- steroid compounds
- active steroid
- preparing therapeutically
- analogical procedure
- Prior art date
Links
- -1 STEROID COMPOUNDS Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3134971A GB1391443A (en) | 1971-07-05 | 1971-07-05 | Ester of betamethasone and its 9alpha-chloro analogue |
Publications (2)
Publication Number | Publication Date |
---|---|
NO137754B NO137754B (no) | 1978-01-09 |
NO137754C true NO137754C (no) | 1978-04-19 |
Family
ID=10321802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2406/72A NO137754C (no) | 1971-07-05 | 1972-07-04 | Analogifremgangsmaate for fremstilling av terapeutisk aktive steroidforbindelser |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS5644079B1 (no) |
AR (2) | AR194120A1 (no) |
AU (1) | AU464251B2 (no) |
BE (1) | BE785812A (no) |
CA (1) | CA983919A (no) |
CH (1) | CH609065A5 (no) |
DE (1) | DE2232827A1 (no) |
DK (1) | DK131474B (no) |
FR (1) | FR2144761B1 (no) |
GB (1) | GB1391443A (no) |
IE (1) | IE36529B1 (no) |
IL (1) | IL39821A (no) |
NL (1) | NL169882C (no) |
NO (1) | NO137754C (no) |
PH (1) | PH13195A (no) |
SE (1) | SE385904B (no) |
ZA (1) | ZA724598B (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS49116217A (no) * | 1973-01-03 | 1974-11-06 | ||
SE418294B (sv) * | 1974-03-27 | 1981-05-18 | Plurichemie Anstalt | Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester |
JPS6163976U (no) * | 1984-10-01 | 1986-05-01 | ||
EP3656385A1 (en) | 2008-05-28 | 2020-05-27 | ReveraGen BioPharma, Inc. | Non-hormonal steroid modulators of nf-kb for treatment of disease |
WO2011127048A2 (en) | 2010-04-05 | 2011-10-13 | Validus Biopharma | NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE |
US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
-
0
- BE BE785812D patent/BE785812A/xx not_active IP Right Cessation
-
1971
- 1971-07-05 GB GB3134971A patent/GB1391443A/en not_active Expired
-
1972
- 1972-07-04 DE DE2232827A patent/DE2232827A1/de not_active Ceased
- 1972-07-04 IE IE939/72A patent/IE36529B1/xx unknown
- 1972-07-04 DK DK331372AA patent/DK131474B/da unknown
- 1972-07-04 JP JP6640472A patent/JPS5644079B1/ja active Pending
- 1972-07-04 NO NO2406/72A patent/NO137754C/no unknown
- 1972-07-04 CA CA146,248A patent/CA983919A/en not_active Expired
- 1972-07-04 SE SE7208817A patent/SE385904B/xx unknown
- 1972-07-04 ZA ZA724598A patent/ZA724598B/xx unknown
- 1972-07-04 IL IL39821A patent/IL39821A/xx unknown
- 1972-07-04 AU AU44205/72A patent/AU464251B2/en not_active Expired
- 1972-07-04 CH CH1003472A patent/CH609065A5/xx not_active IP Right Cessation
- 1972-07-04 AR AR242889A patent/AR194120A1/es active
- 1972-07-04 FR FR7224132A patent/FR2144761B1/fr not_active Expired
- 1972-07-04 NL NLAANVRAGE7209345,A patent/NL169882C/xx not_active IP Right Cessation
- 1972-07-05 PH PH13687A patent/PH13195A/en unknown
-
1973
- 1973-05-21 AR AR248131A patent/AR194553A1/es active
Also Published As
Publication number | Publication date |
---|---|
AU464251B2 (en) | 1975-08-21 |
DE2232827A1 (de) | 1973-01-18 |
AR194120A1 (es) | 1973-06-22 |
SE385904B (sv) | 1976-07-26 |
NO137754B (no) | 1978-01-09 |
FR2144761B1 (no) | 1976-03-05 |
CA983919A (en) | 1976-02-17 |
BE785812A (fr) | 1973-01-04 |
GB1391443A (en) | 1975-04-23 |
DK131474C (no) | 1975-12-08 |
NL169882C (nl) | 1982-09-01 |
CH609065A5 (en) | 1979-02-15 |
IE36529L (en) | 1973-01-05 |
FR2144761A1 (no) | 1973-02-16 |
IL39821A (en) | 1976-02-29 |
ZA724598B (en) | 1973-03-28 |
PH13195A (en) | 1980-01-18 |
AR194553A1 (es) | 1973-07-23 |
NL7209345A (no) | 1973-01-09 |
AU4420572A (en) | 1974-01-10 |
JPS5644079B1 (no) | 1981-10-16 |
NL169882B (nl) | 1982-04-01 |
DK131474B (da) | 1975-07-21 |
IE36529B1 (en) | 1976-11-24 |
IL39821A0 (en) | 1972-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO138805C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive triazolforbindelser | |
NO137440C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pleuromutiliner | |
NO139560C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater | |
NO137694C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner | |
NO136045C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazinoner. | |
NO138999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner | |
NO139127C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylalkylaminer | |
NO136251C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater. | |
NO137858C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner | |
NO140596C (no) | Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner | |
NO137754C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive steroidforbindelser | |
NO137151C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive ortiotropin-peptider | |
FI49827C (fi) | Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-hydroksimetyy li-isokinoliinien valmistamiseksi. | |
NO137728C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater | |
NO138251C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer | |
NO138375C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme cefalosporinderivater | |
SE385706B (sv) | Forfarande for framstellning av terapeutiskt aktiva linkomycinanaloger | |
NO139733C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av metylamin | |
NO140299C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner | |
NO137695C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser | |
NO137727C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener | |
NO137696C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepin-derivater | |
SE386438B (sv) | Forfarande for framstellning av terapeutiskt aktiva derivat av 3-metylamino-tetrahydrokarbazoler innehallande fluor | |
NO136841C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylimidazolidinoner | |
NO137893C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-m-trifluormetylfenyl-2-cyanoalkylaminopropaner |